Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 14;25(16):3700.
doi: 10.3390/molecules25163700.

Annexin A1: A Bane or a Boon in Cancer? A Systematic Review

Affiliations

Annexin A1: A Bane or a Boon in Cancer? A Systematic Review

Thanusha Ganesan et al. Molecules. .

Abstract

Annexin A1 has been extensively investigated as an anti-inflammatory protein, but its role in different types of cancer has not been consolidated in a single systematic review to date. Thus, the aim of this paper is to systematically review and critically analyse 18 studies (in-vivo and in-vitro) to consolidate, in a concerted manner, all the information on differential expression of Annexin A1 in different types of cancer and the role this protein plays in tumorigenesis. Pubmed, Scopus, Web of Science, and ScienceDirect were used for the literature search and the keywords used are "annexin A1," "lipocortin 1," "cancer," "malignancy," "neoplasm," "neoplasia," and "tumor." A total of 1128 articles were retrieved by implementing a standard search strategy subjected to meticulous screening processes and 442 articles were selected for full article screening. A total of 18 articles that adhered to the inclusion criteria were included in the systematic review and these articles possessed low to moderate bias. These studies showed a strong correlation between Annexin A1 expression and cancer progression via modulation of various cancer-associated pathways. Differential expression of Annexin A1 is shown to play a role in cellular proliferation, metastasis, lymphatic invasion, and development of resistance to anti-cancer treatment. Meta-analysis in the future may provide a statistically driven association between Annexin A1 expression and malignancy progression.

Keywords: Annexin A1; cancer; gene expression; lipocortin 1; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram of study selection process.
Figure 2
Figure 2
Schematic representation of differential roles of Anx-A1 in various signaling pathways contributing to the pathophysiology of cancer [47,48,49,50].

Similar articles

Cited by

References

    1. Perretti M., Dalli J. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br. J. Pharmacol. 2009;158:936–946. doi: 10.1111/j.1476-5381.2009.00483.x. - DOI - PMC - PubMed
    1. Rosengarth A., Luecke H. A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J. Mol. Biol. 2003;326:1317–1325. doi: 10.1016/S0022-2836(03)00027-5. - DOI - PubMed
    1. Gerke V., Creutz C.E., Moss S.E. Annexins: Linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 2005;6:449–461. doi: 10.1038/nrm1661. - DOI - PubMed
    1. Sheikh M.H., Solito E. Annexin A1: Uncovering the Many Talents of an Old Protein. Int. J. Mol. Sci. 2018;19 - PMC - PubMed
    1. Perretti M., D’Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009;9:62–70. doi: 10.1038/nri2470. - DOI - PubMed

Publication types

LinkOut - more resources